HD LABS 44Mg Tirsema Hybrid Pen

TIRSEMA 44 is a compounded injectable solution that blends tirzepatide (40 mg) and semaglutide (4 mg) in a pre‑filled pen designed for subcutaneous injection. It is manufactured to high laboratory standards and intended for single‑patient use only.

This combo is generally used for:

Aggressive fat loss / appetite suppression

Improved insulin sensitivity

Reduced cravings & better satiety

Blood sugar control (off-label in many cases)

Key Benefits:

– Weight Management: Supports significant weight loss, with tirzepatide alone showing up to 22.5% body weight reduction over 72 weeks.
– Metabolic Support: Improves glycemic control and insulin sensitivity.
– Appetite Regulation: Reduces hunger and increases feelings of fullness.